• Skip to main content
  • Skip to secondary menu

Dossier.org

Market Intelligence

  • Sponsored Post
  • Market Dossier
  • About
  • Contact

COVID-19 Vaccine

Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development

March 10, 2020 By admin Leave a Comment

Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the Coalition for Epidemic Preparedness (CEPI) awarded an initial funding of $4 million to support Novavax’ efforts to develop a COVID-19 vaccine. CEPI and Novavax are having ongoing discussions on additional funding from … [Read more...] about Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development

Copyright © 2013 Dossier.org